Click for best price
TCR Based Therapy Market Size, Share 2024
The global TCR Based Therapy market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Transduction of Chimeric Antigen Receptor Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of TCR Based Therapy include Adaptimmune Therapeutics, Alaunos Therapeutics, Bristol Myers Squibb, Cellular Biomedicine, Gilead Biosciences, GlaxoSmithKline, Immatics, Immunocore and Lion TCR, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for TCR Based Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TCR Based Therapy. This report contains market size and forecasts of TCR Based Therapy in global, including the following market information:
Global TCR Based Therapy Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the TCR Based Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global TCR Based Therapy Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global TCR Based Therapy Market Segment Percentages, by Type, 2023 (%)
Transduction of Chimeric Antigen Receptor
Transduction of TCR ?/? Heterodimer
Global TCR Based Therapy Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global TCR Based Therapy Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
Global TCR Based Therapy Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global TCR Based Therapy Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies TCR Based Therapy revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies TCR Based Therapy revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adaptimmune Therapeutics
Alaunos Therapeutics
Bristol Myers Squibb
Cellular Biomedicine
Gilead Biosciences
GlaxoSmithKline
Immatics
Immunocore
Lion TCR
Takara Bio
Zelluna Immunotherapy
Outline of Major Chapters:
Chapter 1: Introduces the definition of TCR Based Therapy, market overview.
Chapter 2: Global TCR Based Therapy market size in revenue.
Chapter 3: Detailed analysis of TCR Based Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of TCR Based Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Report Attributes |
Report Details |
Report Title |
TCR Based Therapy Market, Global Outlook and Forecast 2024-2030 |
Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year |
2023 |
Forecast Year |
2031 |
Number of Pages |
61 Pages |
Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 TCR Based Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global TCR Based Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global TCR Based Therapy Overall Market Size
2.1 Global TCR Based Therapy Market Size: 2023 VS 2030
2.2 Global TCR Based Therapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top TCR Based Therapy Players in Global Market
3.2 Top Global TCR Based Therapy Companies Ranked by Revenue
3.3 Global TCR Based Therapy Revenue by Companies
3.4 Top 3 and Top 5 TCR Based Therapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies TCR Based Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 TCR Based Therapy Players in Global Market
3.6.1 List of Global Tier 1 TCR Based Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 TCR Based Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global TCR Based Therapy Market Size Markets, 2023 & 2030
4.1.2 Transduction of Chimeric Antigen Receptor
4.1.3 Transduction of TCR ?/? Heterodimer
4.2 By Type - Global TCR Based Therapy Revenue & Forecasts
4.2.1 By Type - Global TCR Based Therapy Revenue, 2019-2024
4.2.2 By Type - Global TCR Based Therapy Revenue, 2025-2030
4.2.3 By Type - Global TCR Based Therapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global TCR Based Therapy Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics & Ambulatory Centers
5.1.4 Cancer Research Institutes
5.1.5 Others
5.2 By Application - Global TCR Based Therapy Revenue & Forecasts
5.2.1 By Application - Global TCR Based Therapy Revenue, 2019-2024
5.2.2 By Application - Global TCR Based Therapy Revenue, 2025-2030
5.2.3 By Application - Global TCR Based Therapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global TCR Based Therapy Market Size, 2023 & 2030
6.2 By Region - Global TCR Based Therapy Revenue & Forecasts
6.2.1 By Region - Global TCR Based Therapy Revenue, 2019-2024
6.2.2 By Region - Global TCR Based Therapy Revenue, 2025-2030
6.2.3 By Region - Global TCR Based Therapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America TCR Based Therapy Revenue, 2019-2030
6.3.2 US TCR Based Therapy Market Size, 2019-2030
6.3.3 Canada TCR Based Therapy Market Size, 2019-2030
6.3.4 Mexico TCR Based Therapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe TCR Based Therapy Revenue, 2019-2030
6.4.2 Germany TCR Based Therapy Market Size, 2019-2030
6.4.3 France TCR Based Therapy Market Size, 2019-2030
6.4.4 U.K. TCR Based Therapy Market Size, 2019-2030
6.4.5 Italy TCR Based Therapy Market Size, 2019-2030
6.4.6 Russia TCR Based Therapy Market Size, 2019-2030
6.4.7 Nordic Countries TCR Based Therapy Market Size, 2019-2030
6.4.8 Benelux TCR Based Therapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia TCR Based Therapy Revenue, 2019-2030
6.5.2 China TCR Based Therapy Market Size, 2019-2030
6.5.3 Japan TCR Based Therapy Market Size, 2019-2030
6.5.4 South Korea TCR Based Therapy Market Size, 2019-2030
6.5.5 Southeast Asia TCR Based Therapy Market Size, 2019-2030
6.5.6 India TCR Based Therapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America TCR Based Therapy Revenue, 2019-2030
6.6.2 Brazil TCR Based Therapy Market Size, 2019-2030
6.6.3 Argentina TCR Based Therapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa TCR Based Therapy Revenue, 2019-2030
6.7.2 Turkey TCR Based Therapy Market Size, 2019-2030
6.7.3 Israel TCR Based Therapy Market Size, 2019-2030
6.7.4 Saudi Arabia TCR Based Therapy Market Size, 2019-2030
6.7.5 UAE TCR Based Therapy Market Size, 2019-2030
7 TCR Based Therapy Companies Profiles
7.1 Adaptimmune Therapeutics
7.1.1 Adaptimmune Therapeutics Company Summary
7.1.2 Adaptimmune Therapeutics Business Overview
7.1.3 Adaptimmune Therapeutics TCR Based Therapy Major Product Offerings
7.1.4 Adaptimmune Therapeutics TCR Based Therapy Revenue in Global Market (2019-2024)
7.1.5 Adaptimmune Therapeutics Key News & Latest Developments
7.2 Alaunos Therapeutics
7.2.1 Alaunos Therapeutics Company Summary
7.2.2 Alaunos Therapeutics Business Overview
7.2.3 Alaunos Therapeutics TCR Based Therapy Major Product Offerings
7.2.4 Alaunos Therapeutics TCR Based Therapy Revenue in Global Market (2019-2024)
7.2.5 Alaunos Therapeutics Key News & Latest Developments
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Company Summary
7.3.2 Bristol Myers Squibb Business Overview
7.3.3 Bristol Myers Squibb TCR Based Therapy Major Product Offerings
7.3.4 Bristol Myers Squibb TCR Based Therapy Revenue in Global Market (2019-2024)
7.3.5 Bristol Myers Squibb Key News & Latest Developments
7.4 Cellular Biomedicine
7.4.1 Cellular Biomedicine Company Summary
7.4.2 Cellular Biomedicine Business Overview
7.4.3 Cellular Biomedicine TCR Based Therapy Major Product Offerings
7.4.4 Cellular Biomedicine TCR Based Therapy Revenue in Global Market (2019-2024)
7.4.5 Cellular Biomedicine Key News & Latest Developments
7.5 Gilead Biosciences
7.5.1 Gilead Biosciences Company Summary
7.5.2 Gilead Biosciences Business Overview
7.5.3 Gilead Biosciences TCR Based Therapy Major Product Offerings
7.5.4 Gilead Biosciences TCR Based Therapy Revenue in Global Market (2019-2024)
7.5.5 Gilead Biosciences Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline TCR Based Therapy Major Product Offerings
7.6.4 GlaxoSmithKline TCR Based Therapy Revenue in Global Market (2019-2024)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Immatics
7.7.1 Immatics Company Summary
7.7.2 Immatics Business Overview
7.7.3 Immatics TCR Based Therapy Major Product Offerings
7.7.4 Immatics TCR Based Therapy Revenue in Global Market (2019-2024)
7.7.5 Immatics Key News & Latest Developments
7.8 Immunocore
7.8.1 Immunocore Company Summary
7.8.2 Immunocore Business Overview
7.8.3 Immunocore TCR Based Therapy Major Product Offerings
7.8.4 Immunocore TCR Based Therapy Revenue in Global Market (2019-2024)
7.8.5 Immunocore Key News & Latest Developments
7.9 Lion TCR
7.9.1 Lion TCR Company Summary
7.9.2 Lion TCR Business Overview
7.9.3 Lion TCR TCR Based Therapy Major Product Offerings
7.9.4 Lion TCR TCR Based Therapy Revenue in Global Market (2019-2024)
7.9.5 Lion TCR Key News & Latest Developments
7.10 Takara Bio
7.10.1 Takara Bio Company Summary
7.10.2 Takara Bio Business Overview
7.10.3 Takara Bio TCR Based Therapy Major Product Offerings
7.10.4 Takara Bio TCR Based Therapy Revenue in Global Market (2019-2024)
7.10.5 Takara Bio Key News & Latest Developments
7.11 Zelluna Immunotherapy
7.11.1 Zelluna Immunotherapy Company Summary
7.11.2 Zelluna Immunotherapy Business Overview
7.11.3 Zelluna Immunotherapy TCR Based Therapy Major Product Offerings
7.11.4 Zelluna Immunotherapy TCR Based Therapy Revenue in Global Market (2019-2024)
7.11.5 Zelluna Immunotherapy Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. TCR Based Therapy Market Opportunities & Trends in Global Market
Table 2. TCR Based Therapy Market Drivers in Global Market
Table 3. TCR Based Therapy Market Restraints in Global Market
Table 4. Key Players of TCR Based Therapy in Global Market
Table 5. Top TCR Based Therapy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global TCR Based Therapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global TCR Based Therapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies TCR Based Therapy Product Type
Table 9. List of Global Tier 1 TCR Based Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 TCR Based Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global TCR Based Therapy Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - TCR Based Therapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - TCR Based Therapy Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global TCR Based Therapy Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - TCR Based Therapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - TCR Based Therapy Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global TCR Based Therapy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global TCR Based Therapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global TCR Based Therapy Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America TCR Based Therapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America TCR Based Therapy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe TCR Based Therapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe TCR Based Therapy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia TCR Based Therapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia TCR Based Therapy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America TCR Based Therapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America TCR Based Therapy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa TCR Based Therapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa TCR Based Therapy Revenue, (US$, Mn), 2025-2030
Table 30. Adaptimmune Therapeutics Company Summary
Table 31. Adaptimmune Therapeutics TCR Based Therapy Product Offerings
Table 32. Adaptimmune Therapeutics TCR Based Therapy Revenue (US$, Mn) & (2019-2024)
Table 33. Adaptimmune Therapeutics Key News & Latest Developments
Table 34. Alaunos Therapeutics Company Summary
Table 35. Alaunos Therapeutics TCR Based Therapy Product Offerings
Table 36. Alaunos Therapeutics TCR Based Therapy Revenue (US$, Mn) & (2019-2024)
Table 37. Alaunos Therapeutics Key News & Latest Developments
Table 38. Bristol Myers Squibb Company Summary
Table 39. Bristol Myers Squibb TCR Based Therapy Product Offerings
Table 40. Bristol Myers Squibb TCR Based Therapy Revenue (US$, Mn) & (2019-2024)
Table 41. Bristol Myers Squibb Key News & Latest Developments
Table 42. Cellular Biomedicine Company Summary
Table 43. Cellular Biomedicine TCR Based Therapy Product Offerings
Table 44. Cellular Biomedicine TCR Based Therapy Revenue (US$, Mn) & (2019-2024)
Table 45. Cellular Biomedicine Key News & Latest Developments
Table 46. Gilead Biosciences Company Summary
Table 47. Gilead Biosciences TCR Based Therapy Product Offerings
Table 48. Gilead Biosciences TCR Based Therapy Revenue (US$, Mn) & (2019-2024)
Table 49. Gilead Biosciences Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline TCR Based Therapy Product Offerings
Table 52. GlaxoSmithKline TCR Based Therapy Revenue (US$, Mn) & (2019-2024)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Immatics Company Summary
Table 55. Immatics TCR Based Therapy Product Offerings
Table 56. Immatics TCR Based Therapy Revenue (US$, Mn) & (2019-2024)
Table 57. Immatics Key News & Latest Developments
Table 58. Immunocore Company Summary
Table 59. Immunocore TCR Based Therapy Product Offerings
Table 60. Immunocore TCR Based Therapy Revenue (US$, Mn) & (2019-2024)
Table 61. Immunocore Key News & Latest Developments
Table 62. Lion TCR Company Summary
Table 63. Lion TCR TCR Based Therapy Product Offerings
Table 64. Lion TCR TCR Based Therapy Revenue (US$, Mn) & (2019-2024)
Table 65. Lion TCR Key News & Latest Developments
Table 66. Takara Bio Company Summary
Table 67. Takara Bio TCR Based Therapy Product Offerings
Table 68. Takara Bio TCR Based Therapy Revenue (US$, Mn) & (2019-2024)
Table 69. Takara Bio Key News & Latest Developments
Table 70. Zelluna Immunotherapy Company Summary
Table 71. Zelluna Immunotherapy TCR Based Therapy Product Offerings
Table 72. Zelluna Immunotherapy TCR Based Therapy Revenue (US$, Mn) & (2019-2024)
Table 73. Zelluna Immunotherapy Key News & Latest Developments
List of Figures
Figure 1. TCR Based Therapy Segment by Type in 2023
Figure 2. TCR Based Therapy Segment by Application in 2023
Figure 3. Global TCR Based Therapy Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global TCR Based Therapy Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global TCR Based Therapy Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by TCR Based Therapy Revenue in 2023
Figure 8. By Type - Global TCR Based Therapy Revenue Market Share, 2019-2030
Figure 9. By Application - Global TCR Based Therapy Revenue Market Share, 2019-2030
Figure 10. By Type - Global TCR Based Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global TCR Based Therapy Revenue Market Share, 2019-2030
Figure 12. By Application - Global TCR Based Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global TCR Based Therapy Revenue Market Share, 2019-2030
Figure 14. By Region - Global TCR Based Therapy Revenue Market Share, 2019-2030
Figure 15. By Country - North America TCR Based Therapy Revenue Market Share, 2019-2030
Figure 16. US TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 17. Canada TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe TCR Based Therapy Revenue Market Share, 2019-2030
Figure 20. Germany TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 21. France TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 23. Italy TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 24. Russia TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia TCR Based Therapy Revenue Market Share, 2019-2030
Figure 28. China TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 29. Japan TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 32. India TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America TCR Based Therapy Revenue Market Share, 2019-2030
Figure 34. Brazil TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa TCR Based Therapy Revenue Market Share, 2019-2030
Figure 37. Turkey TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 38. Israel TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 40. UAE TCR Based Therapy Revenue, (US$, Mn), 2019-2030
Figure 41. Adaptimmune Therapeutics TCR Based Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Alaunos Therapeutics TCR Based Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Bristol Myers Squibb TCR Based Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Cellular Biomedicine TCR Based Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Gilead Biosciences TCR Based Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. GlaxoSmithKline TCR Based Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Immatics TCR Based Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Immunocore TCR Based Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Lion TCR TCR Based Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Takara Bio TCR Based Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Zelluna Immunotherapy TCR Based Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)